122 related articles for article (PubMed ID: 10142848)
1. Formulary conversion from glipizide to glyburide: a cost-minimization analysis.
Nadel HL
Hosp Pharm; 1995 Jun; 30(6):467-9, 472-4. PubMed ID: 10142848
[TBL] [Abstract][Full Text] [Related]
2. Conversion from glipizide to glyburide: a prospective cost-impact survey.
Alexis G; Henault R; Sparr HB
Clin Ther; 1992; 14(3):409-17. PubMed ID: 1638582
[TBL] [Abstract][Full Text] [Related]
3. Conversion from glipizide to glyburide: long-term follow-up of a cost-impact survey focusing on the elderly.
Alexis G; Henault R; Sparr HB
Clin Ther; 1993; 15(3):607-15. PubMed ID: 8364952
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic.
Law AV; Pathak DS; Segraves AM; Weinstein CR; Arneson WH
Clin Ther; 1995; 17(5):977-87. PubMed ID: 8595649
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of glipizide and glyburide in a health maintenance organization.
Noyes MA; Carter BL; Helling DK; McCormick WC; Ramirez R
Ann Pharmacother; 1992 Oct; 26(10):1215-20. PubMed ID: 1421641
[TBL] [Abstract][Full Text] [Related]
6. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
7. A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose.
Ramsdell JW; Grossman JA; Stephens JM; Botteman MF; Arocho R
Am J Manag Care; 1999 Aug; 5(8):1007-24. PubMed ID: 10558125
[TBL] [Abstract][Full Text] [Related]
8. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
Drexler PG; Lambdin CS
J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
[TBL] [Abstract][Full Text] [Related]
9. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis.
Goetzl L; Wilkins I
J Perinatol; 2002; 22(5):403-6. PubMed ID: 12082477
[TBL] [Abstract][Full Text] [Related]
10. Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
Ramsdell JW; Braunstein SN; Stephens JM; Bell CF; Botteman MF; Devine ST
Pharmacoeconomics; 2003; 21(11):819-37. PubMed ID: 12859222
[TBL] [Abstract][Full Text] [Related]
11. A practical approach to achieving a $950,000 cost savings from a joint anesthesia-pharmacy program.
Durfee DD
Hosp Pharm; 1995 Nov; 30(11):957-8, 961-3. PubMed ID: 10152916
[TBL] [Abstract][Full Text] [Related]
12. Formulary management: antibiotics and therapeutic interchange.
Massoomi F
Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
[TBL] [Abstract][Full Text] [Related]
13. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
Coppola P
Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
[TBL] [Abstract][Full Text] [Related]
14. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
[TBL] [Abstract][Full Text] [Related]
15. Financial impact of formulary revision of second-generation cephalosporins.
Andrews JD; Hafting S
Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
[TBL] [Abstract][Full Text] [Related]
16. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
Rüttimann S; Keck B; Hartmeier C; Maetzel A; Bucher HC
Clin Infect Dis; 2004 Feb; 38(3):348-56. PubMed ID: 14727204
[TBL] [Abstract][Full Text] [Related]
17. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
18. How pharmaceutical controls worked in one Ontario hospital.
McLean WM; Tierney MG
Can J Hosp Pharm; 1994 Aug; 47(4):176-9. PubMed ID: 10136951
[No Abstract] [Full Text] [Related]
19. Inventory management to reduce costs: a case study.
Wilson S
Hosp Pharm; 1995 Sep; 30(9):759-61, 765-6. PubMed ID: 10151280
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.
Thrasher CM; Stefl ME; Dorner FH
Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
